Class 4 Medicines Recall (Caution in Use): Irbesartan / Hydrochorothiazide Teva 300/12.5mg and 300/25mg film-coated tablets – Teva UK

Teva UK Ltd has informed MHRA that an incorrect dosing instruction is present in the Patient Information Leaflet for Irbesartan / Hydrochorothiazide, Teva strength combinations 300/12.5 mg & 300/25 mg. For further details regarding this product recall please click here.